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Cadmium is a heavy transition metal that causes kidney disease via prolonged, low-level  
 
exposure due to circulating metallothioneins. These proteins transport cadmium ions to the  
 
proximal convoluted tubule, where they induce the creation of reactive oxygen species (ROS). 
 
Oxidative damage from ROS can lead to kidney dysfunction and eventually failure. Previous 
 
studies have shown that antioxidants, including quercetin, which is found in most fruits and  
 
vegetables, can lessen cadmium-induced toxicity. In this study, human embryonic kidney cells  
 
were pretreated for one hour with varying concentrations of quercetin ranging from 10 - 100 μM.  
 
This was followed by 24-hour treatment with 30 μM cadmium chloride, and growth was  
 
measured by a cell proliferation assay.  In contrast to previous reports, these studies suggest that  
 
quercetin concentrations above 10 μM result in an increase in cell death, suggesting that  
 
quercetin enhances, rather than inhibits, the toxic effect of cadmium within this concentration  
 
range. To determine if cadmium toxicity induced cell death through activation of the JNK  
 
pathway, the level of JNK phosphorylation was measured by immunoblot analysis. These results  
 
suggest that cadmium alone increases JNK phosphorylation slightly while quercetin activates  
 
JNK in a concentration-dependent manner. This activation was increased up to thirteenfold  
 
when treated with both cadmium and quercetin. Taken together, these studies indicate that  
 
cadmium toxicity induces cell death via the JNK pathway, that quercetin above 10 μM also  
 
exhibits cytotoxic effects through JNK phosphorylation, and that quercetin and cadmium act  
 







Heavy Metals and the Risks Posed 
 
Heavy metals are a group of toxic metals, including cadmium, arsenic, lead, beryllium,  
 
and mercury, that can harm human health. In small quantities, some of these metals are important  
 
components in biological molecules such as enzymes that are necessary for life and different  
 
cellular processes. According to the Occupational Safety and Health Administration (OSHA),  
 
however, large amounts can become hazardous to organisms if accumulation is allowed to occur  
 
in their organ systems (2018). Common patterns of exposure to heavy metals include inhaling  
 
airborne metals, ingesting contaminated food or water, and chronic exposure to low levels  
 
(Prozialeck et al., 2006). The first two of these patterns make all animals and plants susceptible  
 
to the hazards posed by increased concentrations of heavy metals, but chronic exposure to low  
 
levels is unique to humans, particularly to those who work in industrial fields. 
 
As an environmental health problem, heavy metal pollution is largely due to the smelting  
 
and electroplating industries. All of the following areas contribute to this issue: the manufacture  
 
of batteries, dyes, paints, and plastics; the burning of heavy metal-containing waste; the use of  
 
contaminated sludge and phosphate salts as fertilizers; and tobacco use (Prozialeck et al., 2006;  
 











charge, and it does not naturally occur in biological systems, according to the National Center  
 
for Biotechnology Information (NCBI) (2018). The industrial processes unique to cadmium  
 
pollution include refining metals and burning fossil fuels (Wang et al., 2017). These industrial  
 
methods release cadmium particles into the environment, allowing cadmium to permeate the soil  
 
(Hashemi and Farajpour, 2016). From that point, there is a high rate of soil-to-plant transfer,  
 
which results in contamination of the surrounding plants and agriculture (Wang et al., 2017). If  
 
contaminated produce reaches grocery store shelves, the accompanying cadmium can enter  
 
human organ systems. Lastly, cadmium is classified by the International Agency for Research on  
 
Cancer as a group I carcinogen, meaning it conclusively causes cancer in human beings  
 
(Wei-ping et al., 2007). 
 
Cadmium in vivo primarily causes disease via prolonged, low-level exposure (Prozialeck  
 
et al., 2006; Wang et al., 2017; Fujiwara et al., 2012). This is possible due to a family of proteins  
 
called metallothioneins. Metallothioneins are found in several different species of animals, and  
 
they are used for transporting very small amounts of heavy metals in the body that are necessary  
 
for cellular processes (Davis and Cousins, 2000). These proteins are rich in cysteine residues,  
 
which give them the ability to chelate heavy metal ions, as seen in Figure 1 (Grennan, 2011;  
 
Stillman, 1995). Cadmium is one of these heavy metal ions, and binding to metallothionein gives  
 
it the ability to move through systemic circulation (Prozialeck et al., 2006; Renugadevi and  
 






Fig. 1. General binding structure of metallothionein to cadmium. (Stillman, 1995) 
 
and the cadmium-metallothionein complex moves through the liver and heart to deposit itself  
 
into the kidneys (NCBI, 2018). When present in the body, cadmium’s biological half-life extends  
 
from ten to thirty years (Prozialeck et al., 2006; Wang et al., 2017; Fujiwara et al., 2012). During  
 
this extended period of time, cadmium is able to cause disease by inducing oxidative stress  
 




Oxidative stress is defined as the disturbance in the balance between reactive oxygen  
 
species production and the cell’s mechanisms for detoxification of those free radicals (Nelson  
 
and Cox, 2013). It is typically caused by continued oxidative phosphorylation in the  
 
mitochondria when there are higher concentrations of reduced ubiquinone than necessary to meet  
 
the energy needs of the cell (Nelson and Cox, 2013). The production of reactive oxygen species   
 
in oxidative phosphorylation is a nonenzymatic process of generating free radicals (Pham-Huy et  
 
al., 2008). Enzymatic generation of free radicals, on the other hand, occurs in phagocytosis and  
 
prostaglandin synthesis to kill pathogens (Pham-Huy et al., 2008; Robinson, 2008; Zhao et al.,  
 





dysfunction observed in diseases related to aging (Cui et al., 2012). 
 
Additionally, oxidative stress can be caused by heavy metal toxicity, particularly in organ  
 
systems that are regularly exposed to environmental pollutants (Dua et al., 2015). Reactive  
 
oxygen species are produced when molecular oxygen is reduced to superoxide, often in the  
 
mitochondria (Figure 2) (Dua et al., 2015; Dröge, 2002). Superoxide is the precursor of many  
 
reactive oxygen species, including hydrogen peroxide, and if left alone, these reactive oxygen  
 
species can cause oxidative damage (Nelson and Cox, 2013). In the case of cadmium toxicity,  
 
reactive oxygen species directly oxidize several biological macromolecules, particularly lipids,  
 




Fig. 2. Pathways of reactive oxygen species production and clearance. (Dröge, 2002) 
 
damages larger internal cell structures, such as mitochondrial membranes and nuclear envelopes  
 





system to protect itself from oxidative damage (Li et al., 2017; Dröge, 2002). In the presence of  
 
cadmium, however, production of reactive oxygen species has been shown to double (Dua et al.,  
 
2015). These mechanisms are inadequate in protecting the cell’s mitochondria in such extreme  
 
cases of oxidative stress, and the resulting mitochondrial dysfunction is a key contributor to  
 
programmed cell death, also called apoptosis (Prozialeck et al., 2006; Dua et al., 2015). 
 
Apoptosis is one of two types of cell death (Nelson and Cox, 2013). This is a controlled  
 
process regulated by internal cell signaling, and it is an important aspect of normal cell turnover,  
 
growth, and development (Elmore, 2007). The first parameter for cytotoxicity that appears is  
 
typically cell shrinkage, which occurs before other characteristics of apoptotic cells (Nishimura  
 
et al., 2008). These other characteristics are cytochrome c movement from the mitochondria,  
 
caspase activation, and DNA fragmentation (Nishimura et al., 2008). The second type of cell  
 
death is necrosis, which is caused by external cellular injury (Grynberg et al., 2017). While  
 
necrosis is considered the more toxic of these cell death mechanisms, there is overlap in the cell  
 
signaling used in both of these processes (Elmore, 2007). 
 
c-Jun N-terminus Kinase Pathway 
 
Mitochondrial dysfunction is linked to the JNK pathway, or the c-Jun N-terminus kinase  
 
pathway. The JNK pathway is a member of the mitogen activated protein kinase (MAPK)  
 
family, also known as the stress-activated protein kinase family (Chen et al., 2016). Like other  
 
MAPK proteins, JNK plays an important role in the regulation of several cellular processes,  
 





pathway is the JNK protein itself, which influences different cellular outcomes through its  
 
phosphorylation. Phosphorylation occurs at two different sites on the protein, Ser63 and Ser73  
 
(Behrens et al., 1999; Kanda and Miura, 2004). Once JNK is activated via phosphorylation, one  
 
possible result of this pathway is apoptosis, as seen in Figure 3 (Cell Signaling Technology,  
 
2012). The JNK pathway can be activated by growth factors, ultraviolet and gamma radiation,  
 
inflammatory cytokines, and oxidative stress signals, including hydrogen peroxide and other  
 
reactive oxygen species. Reactive oxygen species first activate ASK1, which modifies the  
 
MAPK protein MKK4/7. MKK4/7 phosphorylates JNK at the two specific serine residues. From  
 
this point, phosphorylated JNK (P-JNK) can induce apoptosis in two ways. The first way is  
 
through the nucleus. P-JNK interacts with several transcription factors such as c-Jun and p53 to  
 
produce several pro-apoptotic factors, and these pro-apoptotic factors induce cell death. The  
 
second way P-JNK can cause cell death is through the mitochondria (Liu et al., 2015). P-JNK  
 
interacts with the mitochondrial membrane proteins Bax, Bcl-2, Bim, and Bad, all of which  
 
normally help stabilize different regions of the mitochondrial membrane (Creative Diagnostics,  
 
2010; Srivastava et al., 1999). The role of Bcl-2, for example, is to stabilize cytochrome c  
 
(Srivastava et al., 1999). Cytochrome c is vital to the cell’s energy production because it  
 
transfers electrons from Complex III to Complex IV in the electron transport chain (Nelson and  
 
Cox, 2013). When JNK is activated by phosphorylation, it disrupts these proteins so that they  
 
cannot keep the mitochondrial membrane stable (Srivastava et al., 1999). In the case of Bcl-2,  
 






Fig. 3. JNK signaling pathway. (Cell Signaling Technology, 2012) 
 
membrane to the cytosol (Jin et al., 2006). Cytochrome c’s dislocation is due to the malfunction  
 
of Bcl-2, and Bcl-2 is known to be inactivated by P-JNK (Xing-Ding et al., 2009; Srivastava et  
 
al., 1999). The movement of cytochrome c signals that the electron transport chain is unable to  
 
produce ATP. Without an appropriate amount of ATP, the cell is unable to continue the basic  
 





surrounding tissue. JNK phosphorylation has also been implicated in necrosis; however, the  
 
dislocation of cytochrome c has been specifically linked to apoptosis (Grynberg et al., 2017).  
 
Additionally, it has been shown that JNK phosphorylation increases in the presence of cadmium  
 
(Wang et al., 2017; Chen et al., 2016). As the concentration of cadmium increases, it is likely  
 
that the ratio of P-JNK to total JNK increases, and therefore cell death increases. 
 
Kidney Anatomy, Physiology, Pathology, and Cadmium Toxicity 
 
The outcomes of cadmium toxicity and the involvement of the JNK pathway are relevant  
 
because they affect the structure and function of the kidneys in vivo. The kidneys have two  
 
functions: to filter blood for the regulation of water, salt, acidity, and nutrients, and to excrete  
 
metabolic waste products and foreign chemicals (Pearce, 2008; Widmaier et al., 2014).  
 
Concerning the gross anatomy, kidneys have an outer renal cortex and an inner renal medulla  
 
(Gosling et al., 2017). Each medullary pyramid has a renal papilla at its tip. The papilla drains  
 
into minor and major calyces, which collect urine at the renal pelvis. The renal pelvis funnels  
 
into the ureter to transport urine to the bladder.  
 
On a microscopic scale, kidneys are composed of functional units called nephrons  
 
(Figure 4). There are approximately 1.2 million nephrons in each kidney on average, and each  
 
nephron consists of a renal corpuscle and a tubule (Pearce, 2008; Widmaier et al., 2014). The  
 
renal corpuscle, also called the glomerulus, filters the blood from the afferent arteriole and forms  
 
a filtrate of nutrients and waste. The tubule is divided into four parts: the proximal convoluted  
 






Fig. 4. Constituents of the nephron. (Pearce, 2008) 
 
convoluted tubule and the distal convoluted tubule are located generally within the renal cortex,  
 
and the loop of Henle and the collecting duct can be found in the renal medulla. Each part of the  
 
tubule has a single layer of epithelium, which allows for an exchange of nutrients and waste  
 
between the filtrate and the blood in the peritubular capillary network. This epithelial cell layer,  
 
while small, is responsible for proper renal function, and injury to this tissue can result in kidney  
 
failure (Widmaier et al., 2014). 
 
 There are two major types of renal failure: acute renal failure and chronic renal disease  
 
(Mayo Clinic, 2018 and 2015). Acute renal failure is the rapid onset of elevated blood urea  
 
nitrogen or creatinine in combination with a small amount or no urine production (Kemp et al.,  
 
2007). This kind of kidney failure often occurs when a patient has presented to the hospital for a  
 





like blood loss, myocardial infarctions, or glomerulonephritis can be precursors to acute kidney  
 
failure (Mayo Clinic, 2015). Treatment for acute failure is dependent on its cause, such as  
 
intravenous fluid to restore blood loss or medications to control electrolytes in the case of heart  
 
disease (Pearce, 2008). 
 
While acute renal failure has a rapid onset, chronic renal failure consists of the slow  
 
development of renal fibrosis, which is scar tissue resulting from repeated inflammatory  
 
responses (Matovinović, 2009). The severity of chronic renal failure is classified by the  
 
glomerular filtration rate, or the rate at which the renal corpuscle filters the blood (Matovinović,  
 
2009; Widmaier, 2014). A normal, healthy kidney has a glomerular filtration rate of greater than  
 
90 mL/min., while in end-stage renal disease, the worst type of chronic kidney failure, the kidney  
 
has a glomerular filtration rate of 15 mL/min. or less. For end-stage renal disease, patients have  
 
only two options (Mayo Clinic, 2018). The first is a kidney transplant from a donor with a  
 
healthy kidney (Mayo Clinic, 2018). This procedure can be successful when medications are  
 
taken for the rest of the patient’s life to prevent organ rejection and also depends on the  
 
availability of a kidney match (Mayo Clinic, 2018). The second option is dialysis, a process  
 
involving the artificial filtration of a patient’s blood with either a hemodialysis machine or a  
 
peritoneal dialysis catheter inserted into the abdomen (Mayo Clinic, 2018). Should a patient  
 
choose to discontinue dialysis, the life expectancy of that patient is generally a few months  
 
(Mayo Clinic, 2018). 
 





metallothionein, the bloodstream protein designed to bind metal ions (Fujiwara et al., 2012).  
 
After it binds to cadmium, the cadmium-metallothionein complex travels through the  
 
bloodstream and the renal corpuscle into the proximal convoluted tubule, where it is reabsorbed  
 
into the first two-thirds of the tubule known as the S1 and S2 segments (Renugadevi and Prabu,  
 
2009). The protein complex is then degraded by the lysosome, and this degradation releases  
 
cadmium into those epithelial cells. An accumulation of cadmium, even in low concentrations,  
 
will cause oxidative damage to the glomerulus via the production of reactive oxygen species  
 
(Wei-ping et al., 2007; Chen et al., 2016). Additionally, chronic exposure to cadmium stimulates  
 
fibrosis due to oxidative stress-induced apoptosis and inflammatory signaling (Chen et al., 2016;  
 
Matovinović, 2009; Pham-Huy et al., 2008; Grynberg et al., 2017). The buildup of scar tissue  
 
that occurs with fibrosis interferes with the kidney’s ability to function, and this condition can  
 
lead to chronic kidney disease (Chen et al., 2016).  
 
Quercetin and the Power of Antioxidants 
 
 Antioxidants are chemicals that counteract oxidative stress in biological systems  
 
(Pham-Huy et al., 2008). Endogenous antioxidants are produced within the biological system  
 
under oxidative stress, and these built-in mechanisms are known as the antioxidant system  
 
(Pham-Huy et al., 2008; Li et al., 2017). The antioxidant system consists of seven enzymes:  
 
superoxide dismutase, catalase, glucose-6-phosphate dehydrogenase, glutathione-S-transferase,  
 
glutathione peroxidase, glutathione reductase, and reduced glutathione (Li et al., 2017). In  
 





free radicals harmless. With increased oxidative stress, such as that which cadmium induces,  
 
endogenous antioxidants are not able to protect the affected tissue alone (Dua et al., 2015). In  
 
those circumstances, exogenous antioxidants supplied from one’s diet can assist in protecting  
 
cells from the increase in oxidative stress (Anantachoke et al., 2016). 
 
Exogenous antioxidants such as flavonoids have shown promise in protecting cells from  
 
cadmium-induced oxidative damage (Donpugha et al., 2011, Pappas et al., 2010). Flavonoids are  
 
a class of plant and fungal secondary metabolites classified by a 15-carbon skeleton with two  
 
phenyl rings and a heterocyclic ring in the middle (Pappas et al., 2010). Known to be strong  
 
antioxidants and free radical scavengers, this class of molecules can prevent or delay  
 
cardiovascular diseases, inflammation, aging, and Alzheimer’s disease, among other chronic  
 
conditions (Prabu et al., 2013; Pham-Huy et al., 2008). One of the most common flavonoids,  
 
found in most fruits and vegetables as well as tea, coffee, and red wine, is quercetin, whose  
 
structure is shown in Figure 5 (Kelly, 2011). Quercetin’s nomenclature according to the  
 
International Union of Pure and Applied Chemistry (IUPAC) is 3,3’,4’,5,7-pentahydroxy-2-  
 
phenylchromen-4-one (Kelly, 2011). Its several hydroxyl groups are the primary reason why it is  
 
a strong antioxidant and free radical scavenger. These antioxidant properties are attributed to its  
 
ability to chelate transition metal ions, including cadmium (Prabu et al., 2013). Cells show  
 
significant uptake of quercetin, particularly in the mitochondria (Kelly, 2011). Quercetin has  
 
other beneficial qualities; its effects can cause a decrease in allergies, cancer, blood pressure, and  
 






Fig. 5. Quercetin chemical composition. (Kelly, 2011) 
 
observable in vitro.  
 
 Several previous studies in vivo have measured protective effects by quercetin in  
 
response to cadmium toxicity. For example, Prabu et al. demonstrated that quercetin pre- 
 
treatment can ameliorate cadmium-induced oxidative pathology in rat cardiovascular systems  
 
(2013). In a different study from Dua et al., researchers examined mouse hepatocytes for  
 
cadmium-induced oxidative stress after treatment with a plant-aqueous extract rich in quercetin  
 
(2015). Their histological analysis showed that the quercetin-rich plant extract pre-treatment  
 
effectively kept the tissue almost completely protected from cell death (Dua et al., 2015).  
 
Additionally, Li et al. reported that a different quercetin-rich plant extract improved bone  
 
mineral status in osteoporosis with cadmium exposure (2017). 
 
Compared to these in vivo studies, in vitro studies can have different conclusions. One  
 
such study found that quercetin concentrations of 40 μM and above had cytotoxic effects on  
 





lowered rat thymocyte growth (Nishimura et al., 2008). Quercetin, therefore, can exhibit  
 
antiproliferative activity under certain circumstances (Kelly, 2011). While in vitro research is  
 
less immediately applicable to human biological systems, it is preferable for elucidating the  
 
mechanism of a particular pathway. Because the various conditions surrounding cell growth can  
 
be controlled much more closely, researchers who study the JNK pathway have historically used  
 
cell lines cultured in vitro (Jin et al., 2006; Srivastava et al., 1999; Behrens et al., 1999). The  
 
purpose of this thesis, therefore, is fourfold: first, to observe cadmium-induced toxicity in kidney  
 
epithelial cells; second, to explore how quercetin affects kidney cell proliferation; third, to  
 
determine the effects of quercetin and cadmium in kidney epithelial cells when treated  
 
simultaneously; and fourth, to determine if the phosphorylation of JNK is involved in this  
 
























Cell Culture and Solutions for Treatments 
  
         HEK 293 cells were purchased from American Type Culture Collection (ATCC)  
 
(Manassas, VA) and grown in VWR T25 flasks (Radnor, PA) using Eagle’s Minimum Essential  
 
Medium (EMEM) from Lonza (Miami, FL). Quercetin and dimethyl sulfoxide (DMSO) were  
 
purchased from Sigma-Aldrich (St. Louis, MO). Quercetin was diluted using DMSO to make  
 
solutions with concentrations of 1 mM, 5 mM, 10 mM, and 20 mM. Cadmium chloride (CdCl2)  
 
solutions with the following concentrations were made from stock 10 mM CdCl2 solutions and  
 
sterile 10 mM HEPES: 0.2 mM, 0.6 mM, 1 mM, 2 mM, and 4 mM. 
  
Plating, Treating, and Cell Proliferation Assay 
  
         Upon confluence, cells were trypsinized, centrifuged at 2000 xg for 2 min., counted, and  
 
seeded in a 96-well plate at 5,000 cells/well with 190 μL of media added to each well (Liu et al.,  
 
2015). Cells were allowed to grow for 24 hours, and then treatments were administered. CdCl2  
 
treatments diluted in 10 mM HEPES were added in 10 μL volumes while quercetin  
 
concentrations diluted in DMSO were maintained at 2 μL volumes. DMSO and 10 mM HEPES  
 
were used as controls. For wells containing both CdCl2 and quercetin, the quercetin pre- 
 
treatment was administered 1 hour prior to the CdCl2 treatment (Chen et al., 2016). Each  
 
treatment was given in quadruplicate, and treated cells were incubated for 24 hours. Prior to the  
 
proliferation assay, the wells were rinsed with media twice to remove all traces of quercetin so  
 





tetrazolium (MTT) cell proliferation assay, the CellTiter 96® Aqueous One Solution from  
 
Promega (Madison, WI) was used to measure the rate of respiration following manufacturer’s  
 
directions. Absorbances were read on a BioTek ELx808 plate reader (Winooski, VT) with Gen5  
 
3.02 software at an absorbance of 490 nm. The MTT assay was run for 5 hours on average. 
  
Collection of Cell Extracts 
  
         Cells were plated at 600,000 cells/well in 60 mm3 plates and were allowed to grow for 24  
 
hours. Quercetin diluted in DMSO was pre-treated for 1 hour in concentrations of 10 μM, 50  
 
μM, and 100 μM, and CdCl2 treatments diluted in 10 mM HEPES were added to a final  
 
concentration of 30 μM. Cell lysates were prepared in RIPA buffer from Sigma Aldrich  
 
and with Lipofectin phosphatase and protease inhibitors from Life Technologies (Gaithersburg,  
 
MD) according to manufacturer’s directions. Cells were washed two times with cold PBS and  
 
then lysed. Cell lysates were collected using a cell scraper, sonicated twice for 1 second, and  
 
spun at 12,000 rpm for 10 minutes at 4 °C. Supernatant was collected and stored at -80 °C. 
 
Bradford Assay, Immunoblot Analysis, and Densitometric Analysis 
 
 To measure protein concentrations in cell lysates, bovine serum albumin from Sigma  
 
Aldrich was used to prepare a standard curve according to manufacturer’s directions.  
 
Absorbance of the cell lysates was measured at 595 nm by a Genesys 10 uv spectrophotometer  
 
from Fisher Scientific (Hampton, NH). After calculating the protein concentrations, the protein  
 
samples (28.9 μg) were separated on a 4-20% polyacrylamide gel at 200 V and transferred to a  
 





After blocking with 5% milk in Tris buffer saline with 0.1% Tween 20 for 1 hour,  
 
immunoblot analysis was performed using a polyclonal antibody raised to phosphorylated-JNK  
 
(Cell Signaling Technology, Danvers, MA) in a 1/1000 dilution overnight. The membrane was  
 
then incubated with horseradish peroxidase-conjugated goat anti-rabbit antibody for 1 hour  
 
(Thermo Scientific, Waltham, MA). Bands were visualized using ECL reagents and the  
 
Chemidoc Imaging System from BioRad Laboratories (Hercules, CA). The blot was stripped  
 
using Restore Western Blot Stripping Buffer (Thermo Scientific) and retreated with a polyclonal  
 
antibody raised to total-JNK (Cell Signaling Technology) in a 1/500 dilution overnight at 4 °C.  
 
Following the secondary antibody, the blot was developed as previously described.  
 
Densitometric analysis was performed afterwards with Un-Scan It Graph Digitizer Software  
 
(Silk Scientific, Orem, UT) to compare phosphorylated JNK with total JNK, and the results were  
 























To determine if quercetin is able to provide protection against cadmium toxicity, it was  
 
first important to establish the optimal concentrations of cadmium that induced cell death in  
 
human kidney epithelial cells using the cell line HEK 293. Cells were treated with increasing  
 
concentrations of cadmium for 24 hours, and a cell proliferation assay was then used to measure  
 




Fig. 6. Cell proliferation assay with various treatments of cadmium chloride. Cells were seeded at a 
cellular density of 5×103 cells/well. They were then treated with the increasing concentrations of CdCl2 
for 24 hours.  An MTT assay was performed to measure the rate of cell proliferation (quantified by the 
absorbance at 490 nm) with each concentration. 
 
Compared to no treatment, 10 mM HEPES (used as the vehicle for cadmium) and 10 μM  
 
cadmium chloride have little, if any, effect on cell proliferation. As the concentration of  
 





with the lowest amount of growth coinciding with the 100 μM cadmium chloride treatment.  
 
Because 30 μM cadmium initiated an observable toxic response without resulting in immediate  
 
cell death, this concentration was used in all of the following experiments. 
 
To determine how quercetin may affect kidney epithelial cell proliferation, HEK 293  
 
cells were seeded and treated with increasing concentrations of quercetin for 24 hours. Cell  
 
growth was again measured using a cell proliferation assay. As shown in Figure 7, 10 mM  
 




Fig. 7. Cell proliferation assay with various treatments of quercetin. Cells were seeded at a cellular 
density of 5×103 cells/well 24 hours prior to quercetin treatments. Cells were then treated with the 
increasing concentrations of quercetin for 24 hours. An MTT assay was performed to measure the rate of 
cell proliferation (quantified by the absorbance at 490 nm) with each concentration. 
 
Surprisingly, the quercetin treatments decreased cell viability when cells were treated with 10  
 





likely that this is related to the methodology used in this study. Quercetin is a yellow pigment,  
 
and if not all of the pigment is removed before the proliferation assay, it could skew the  
 
absorption readings.  Repeated experiments have supported that an increase in quercetin  
 
concentration results in increasing cell death (data not shown).  
 
Previous studies have shown that quercetin has a protective effect against cadmium  
 
toxicity, yet the results from the present study suggest that quercetin alone decreases cell  
 
proliferation. In comparison to cadmium, it is clear that cadmium toxicity has a greater effect on  
 
cell growth. To determine if quercetin might protect against the toxic effect of cadmium or  
 
synergistically increase cell death, kidney cell proliferation was measured in the presence of both  
 
quercetin and cadmium. In this experiment, HEK 293 cells were pre-treated with increasing  
 
concentrations of quercetin for 1 hour, followed by treatment with 30 μM cadmium chloride for  
 
24 hours. As shown in in Figure 8, 30 μM cadmium and increasing concentrations of quercetin  
 
alone both result in decreased cell growth as previously observed. Treatment with both 30 μM  
 
cadmium and increasing concentrations of quercetin shows a slight increase in cell death  
 
compared to either alone. This result suggests that there may be a synergistic effect between  
 
cadmium and quercetin that further induces cell death. 
 
 Other studies have shown that JNK phosphorylation is induced in the presence of  
 
cadmium, suggesting that cadmium may induce cell death by activating the apoptotic pathway.  
 
To determine if both cadmium and quercetin can activate phosphorylation of JNK, HEK 293  
 







Fig. 8. Cell proliferation assay with quercetin pre-treatment and cadmium treatment. Cells were 
seeded at a cellular density of 5×103 cells/well 24 hours before quercetin treatments. Cells were treated 
with quercetin for 1 hour prior to treatment with 30 µM CdCl2. An MTT assay was performed 24 hours 
later to measure the rate of cell proliferation (quantified by the absorbance at 490 nm) with each 
treatment. 
 
treatment with 30 μM cadmium chloride for 1 hour. Immunoblot analysis was then performed to  
 
measure levels of phosphorylated JNK compared to total JNK as a loading control. As shown in  
 
Figure 9, very little JNK is phosphorylated following treatment with 30 μM cadmium. In  
 
contrast, JNK phosphorylation is clearly observed following treatment with increasing  
 
concentrations of quercetin. When cells were treated with both cadmium and quercetin, the  
 
increase in JNK phosphorylation is even greater. (Note that due to a possible mistake in the  
 
experimental design, no data was collected from the sample containing cadmium chloride and 50  
 
μM quercetin). To determine the levels of JNK phosphorylation, these results were quantified  
 







Fig. 9. Immunoblot analysis of phosphorylated JNK and total JNK in cell lysates. Cells were plated 
at 6×105 cells/well in 60 mm3 plates and were allowed to grow for 24 hours. Treatments were added with 
the same concentrations in previous experiments.  
 
in a small, 2.3-fold increase in the ratio of P-JNK to total JNK. With increasing concentrations of  
 
quercetin, JNK phosphorylation also increases in a concentration-dependent manner. When  
 
quercetin pre-treatment is administered in conjunction with cadmium chloride, the P-JNK / total  
 
JNK ratio increases even further, reaching a 4.8-fold increase compared to cadmium alone.  
 
These results suggest that both cadmium and quercetin activate phosphorylation of JNK and that  
 







Fig. 10. Densitometric analysis of phosphorylated JNK and total JNK in cell lysates. The images of 
the immunoblot analysis in Figure 9 were analyzed for density using graph digitizer software to calculate 

























To study the effect of cadmium toxicity in HEK 293 cells, it was first important to  
 
determine the amount of cadmium chloride necessary to induce toxicity in the HEK 293 human  
 
kidney epithelial cell line. After treating cells with 10 - 100 μM cadmium chloride for 24 hours,  
 
the results showed that cell proliferation was inhibited in a concentration-dependent manner.  
 
This data is consistent with previous published studies addressing cadmium toxicity. Prozialeck  
 
et al. showed that 15-hour cadmium treatments to human umbilical vein endothelial cells  
 
disrupted cell structure in a concentration-dependent manner (2006). In a different study by  
 
Wang et al., adult neural progenitor cells from the subventricular zone of rat brain were treated  
 
with cadmium for 24 hours, and cell proliferation was shown to decrease due to apoptosis  
 
(2017). In the remaining studies in this project, 30 μM cadmium chloride was used because it  
 
was strong enough to reduce cell growth but did not completely inhibit viability. This provided  
 
an optimal concentration that provided the opportunity to test the effects of quercetin.   
 
In the face of oxidative damage, the use of antioxidants such as quercetin has shown  
 
promise in protecting cells from cadmium toxicity. Feeding plant extracts containing quercetin to  
 
mice was found to protect the livers of these mice from cadmium toxicity and their bones from  
 
osteoporosis (Li et al., 2017; Dua et al., 2015). Also, rats treated with quercetin had healthier  
 
cardiovascular systems than rats treated with cadmium (Prabu et al., 2013). Each of these  
 
studies, however, were conducted in vivo. Previous in vitro studies have suggested that quercetin  
 





various chemotherapeutic agents decreased cell viability in an ovarian cancer cell line (2014).  
 
Another study by Nishimura et al. found that 30 μM quercetin treatments induced apoptosis in  
 
rat thymocytes, but their quercetin concentrations of 10 μM and below did not differ significantly  
 
from the control treatment (2008). In the present study, it was observed that treatment with 10 -  
 
100 μM quercetin for 24 hours inhibited cellular growth in a concentration-dependent manner. 
  
These previous studies concerning the effects of cadmium and quercetin have conflicting  
 
results. At times, quercetin exhibits protective effects in the presence of oxidative damage, but  
 
conversely, quercetin itself induces cell death. In the present study, it was found that a one-hour  
 
quercetin pre-treatment does not lessen cadmium-induced cytotoxicity. Rather, the combined  
 
effect of cadmium chloride and quercetin lowers cell proliferation even further. Based on these  
 
observations, it appears that decreased concentrations of quercetin, 10 μM and lower, may  
 
protect cells from oxidative damage due to cadmium. Further studies are necessary to determine  
 
if concentrations lower than 10 μM have a protective effect. Above 10 μM, however, quercetin  
 
compounds the effects of cadmium and increases the levels of cell death.  
 
Regarding cadmium cytotoxicity, previous studies corroborate the involvement of the  
 
JNK pathway. Once JNK is phosphorylated, cell death is known to occur, typically by means of  
 
apoptosis (Behrens et al., 1999). Wang et al. treated rat adult neural progenitor cells with 0.45  
 
μM cadmium chloride and found that the cadmium treatment yielded a twelvefold induction of  
 
phosphorylated JNK after 30 minutes (2017). Chen et al. also found that treatment of 4 μM  
 





total JNK from 1 to 10 over a 12-hour period (2016). Additionally, when these human renal  
 
mesangial cells were pre-treated with the JNK inhibitor SP600125, cadmium treatment did not  
 
significantly change the amount of JNK phosphorylation (Chen et al., 2016). 
 
In this study, it was observed with immunoblot analyses that phosphorylation of JNK  
 
increases in the presence of quercetin in a concentration-dependent manner. Phosphorylation of  
 
JNK was also observed in the presence of cadmium, but at a much lower effect, with only a two- 
 
fold increase in the ratio of phosphorylated JNK to total JNK. At its highest concentration of 100  
 
μM, quercetin alone more strongly induces JNK phosphorylation than cadmium chloride. When  
 
the two compounds are both present, the ratio of phosphorylated JNK to total JNK increases  
 
even further. These results suggest that both cadmium chloride and quercetin activate the JNK  
 
pathway individually at these concentrations, and combining quercetin pre-treatment with  
 
cadmium chloride treatment creates a synergistic effect on JNK phosphorylation. 
 
From these studies, it is clear that quercetin induces cell death to the same degree as  
 
cadmium chloride, and quercetin pre-treatment prior to cadmium chloride treatment exacerbates  
 
the observed cadmium-induced toxicity. Both quercetin and cadmium chloride likely induce cell  
 
death through the JNK pathway via JNK phosphorylation. Based on previous reports,  
 
phosphorylated JNK then disrupts mitochondrial function and increases the transcription and  
 
translation of apoptotic factors. These events in the mitochondria produce reactive oxygen  
 
species, which further contribute to the destruction of the cell (Prozialeck et al., 2006).  
 





necessary to keep the balance of cell division intact (Widmaier, et al., 2014). When this occurs  
 
across a section of epithelial tissue in the proximal convoluted tubule, however, that section of  
 
nephron becomes dysfunctional. Secretion and reabsorption of the filtrate cannot occur, and the  
 
epithelial tissue cannot regenerate without healthy cells present. Renal function decreases overall  
 
in this manner, and if an individual is exposed to enough cadmium pollution or contamination  
 
over their lifetime, then that individual is condemned to dialysis treatments at the end of their life  
 
unless a kidney transplant is a viable option. Understanding the JNK pathway and its interactions  
 
with cadmium and quercetin is critical to finding a treatment for kidney failure and for  
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